A component of lobular carcinoma in clinically lymph node–negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer

by Renae D. Van Wyhe, MBA, Abigail S. Caudle, MD, Simona F. Shaitelman, MD, George H. Perkins, MD, Thomas A. Buchholz, MD, Karen E. Hoffman, MD, Eric A. Strom, MD, Benjamin D. Smith, MD, Welela Tereffe, MD, Wendy A. Woodward, MD, PhD, Michael C. Stauder, MD
Published 2018-07-01